KPRX logo

Kiora Pharmaceuticals (KPRX) Current Liabilities

Annual Current Liabilities

$1.63 M
-$1.64 M-50.07%

December 1, 2023


Summary


Performance

KPRX Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKPRXbalance sheetmetrics:

Quarterly Current Liabilities

$3.53 M
+$1.87 M+113.03%

September 1, 2024


Summary


Performance

KPRX Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKPRXbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

KPRX Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-50.1%+67.9%
3 y3 years-17.7%+87.3%
5 y5 years-57.7%+87.3%

KPRX Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-50.1%+1.5%at high+121.5%
5 y5-year-50.1%+15.5%at high+344.2%
alltimeall time-89.0%+118.7%-76.2%+754.8%

Kiora Pharmaceuticals Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$3.53 M(+113.0%)
Jun 2024
-
$1.66 M(+4.0%)
Mar 2024
-
$1.59 M(-2.5%)
Dec 2023
$1.63 M(-50.1%)
$1.63 M(-22.2%)
Sep 2023
-
$2.10 M(+11.6%)
Jun 2023
-
$1.88 M(-12.6%)
Mar 2023
-
$2.16 M(-34.1%)
Dec 2022
$3.27 M(+103.3%)
$3.27 M(+9.3%)
Sep 2022
-
$2.99 M(+4.8%)
Jun 2022
-
$2.86 M(+13.3%)
Mar 2022
-
$2.52 M(+56.7%)
Dec 2021
$1.61 M(-18.9%)
$1.61 M(-17.8%)
Sep 2021
-
$1.96 M(+36.4%)
Jun 2021
-
$1.44 M(+0.8%)
Mar 2021
-
$1.43 M(-28.2%)
Dec 2020
$1.98 M(+40.3%)
$1.98 M(+113.4%)
Sep 2020
-
$930.20 K(+14.0%)
Jun 2020
-
$815.70 K(+2.7%)
Mar 2020
-
$794.20 K(-43.9%)
Dec 2019
$1.41 M
$1.41 M(-35.0%)
Sep 2019
-
$2.18 M(+130.6%)
Jun 2019
-
$943.80 K(+2.6%)
DateAnnualQuarterly
Mar 2019
-
$919.90 K(-76.2%)
Dec 2018
$3.86 M(-73.9%)
$3.86 M(-7.1%)
Sep 2018
-
$4.16 M(+0.9%)
Jun 2018
-
$4.12 M(-8.2%)
Mar 2018
-
$4.49 M(-69.7%)
Dec 2017
$14.83 M(+103.0%)
$14.83 M(+17.4%)
Sep 2017
-
$12.64 M(+14.9%)
Jun 2017
-
$11.00 M(+5.8%)
Mar 2017
-
$10.40 M(+42.3%)
Dec 2016
$7.31 M(+113.6%)
$7.31 M(+18.6%)
Sep 2016
-
$6.16 M(+20.7%)
Jun 2016
-
$5.11 M(-9.6%)
Mar 2016
-
$5.65 M(+65.2%)
Dec 2015
$3.42 M(-31.9%)
$3.42 M(+142.8%)
Sep 2015
-
$1.41 M(+119.2%)
Jun 2015
-
$642.60 K(+55.7%)
Mar 2015
-
$412.70 K(-91.8%)
Dec 2014
$5.02 M(+95.4%)
$5.02 M(+3.7%)
Sep 2014
-
$4.84 M(-0.0%)
Jun 2014
-
$4.84 M(+47.4%)
Mar 2014
-
$3.29 M(+27.9%)
Dec 2013
$2.57 M(+244.2%)
$2.57 M
Dec 2012
$747.10 K
-

FAQ

  • What is Kiora Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for Kiora Pharmaceuticals?
  • What is Kiora Pharmaceuticals annual current liabilities year-on-year change?
  • What is Kiora Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Kiora Pharmaceuticals?
  • What is Kiora Pharmaceuticals quarterly current liabilities year-on-year change?

What is Kiora Pharmaceuticals annual total current liabilities?

The current annual current liabilities of KPRX is $1.63 M

What is the all time high annual current liabilities for Kiora Pharmaceuticals?

Kiora Pharmaceuticals all-time high annual total current liabilities is $14.83 M

What is Kiora Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, KPRX annual total current liabilities has changed by -$1.64 M (-50.07%)

What is Kiora Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of KPRX is $3.53 M

What is the all time high quarterly current liabilities for Kiora Pharmaceuticals?

Kiora Pharmaceuticals all-time high quarterly total current liabilities is $14.83 M

What is Kiora Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, KPRX quarterly total current liabilities has changed by +$1.43 M (+67.92%)